Astera Cancer Care
Astera Cancer Care is a physician-owned, multi-specialty community oncology practice operating 15+ clinic locations across Central New Jersey and Pennsylvania, delivering medical oncology, radiation oncology, hematology, breast care, infusion, pharmacy, and clinical trial services through a 90+ provider team.
- Company typePrivate
- Founded2021
- HeadquartersEast Brunswick, United States
- Headcount101–250
- GTM typeB2C
- OfferingServices
What Astera Cancer Care does
Astera Cancer Care is a physician-owned, multi-specialty community oncology practice headquartered in East Brunswick, New Jersey, delivering coordinated, patient-centered cancer and blood disorder care across 15+ clinic locations in Central New Jersey and Pennsylvania. The platform integrates medical oncology (chemotherapy, immunotherapy, CAR T-cell therapy), radiation oncology (IMRT, SBRT, SRS, TomoTherapy, HDR/LDR brachytherapy, proton therapy via the ProCure Proton Therapy Center in Somerset, DIBH, and SpaceOAR Hydrogel), hematology, breast surgery and breast care, infusion services for chronic conditions (Rheumatoid Arthritis, Multiple Sclerosis, Asthma), on-site specialty pharmacy, palliative care, social work, nutrition, and clinical trials. The practice fields 90+ multidisciplinary providers including medical oncologists, radiation oncologists, breast surgeons, pharmacists, advanced practice providers, and social workers, and maintains QOPI certification evidencing standardized oncology quality controls.
The business model is fee-for-service healthcare delivery reimbursed primarily through insurance, augmented by clinical trial conduct revenue and research partnerships. Astera distributes services via direct patient care at clinic sites, a healthcare provider referral network, and embedded radiation oncology departments within hospital systems (Saint Peter's University Hospital, Hunterdon Regional Cancer Center, Penn Medicine Princeton Medical Center, Mercy Fitzgerald Hospital, St. Mary Regional Cancer Center). As a partner practice within the OneOncology network, Astera leverages shared practice management, technology, and operational infrastructure, and collaborates with the START Center for Cancer Research to expand early-phase clinical research access in a regional market of approximately 10 million addressable residents and roughly 150,000 new cancer cases annually. The practice is the result of a merger that brought NJHOA under the Astera brand, and is affiliated with Astera Urology and Princeton Radiation Oncology as network partners.
Ownership remains physician-led, with CEO Edward J. Licitra, MD, PhD, President Bruno S. Fang, MD (NIH-trained in medical oncology and hematology), and Chief Medical Officer Ellen A. Ronnen, MD (Memorial Sloan Kettering-trained). Operational leadership includes Vice Presidents overseeing clinical operations and pharmacy, Directors of Clinical Research (with credentials from Yale, Dartmouth-Hitchcock, Johns Hopkins, and Rutgers), Social Work, Specialty Infusion Pharmacy, and Advanced Practice Providers. No external private equity, venture capital, or institutional investment ownership signals were identified in the available data; the practice appears to maintain physician ownership and control within the OneOncology partnership framework.
Astera Cancer Care firmographics
Firmographics- Name
- Astera Cancer Care
- Legal name
- Astera Cancer Care
- Website
- https://asteracancercare.org
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Astera Cancer Care is a physician-owned, multi-specialty community oncology practice operating 15+ clinic locations across Central New Jersey and Pennsylvania, delivering medical oncology, radiation oncology, hematology, breast care, infusion, pharmacy, and clinical trial services through a 90+ provider team.
- Ownership category
- akta.pro rank
Astera Cancer Care industry classification
Industry- Product category
- Oncology and Hematology Healthcare Services
- NAICS
- Offices of Physicians (6211), Offices of Physicians (62111)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)
- akta.pro primary industry
- Medical Oncology (HLAKAFAB)
- akta.pro secondary industries
- Radiation Oncology (HLAKAFAC), Surgical Oncology (HLAKAFAG), Breast Oncology (HLAKAFAJ)
Keywords
Where Astera Cancer Care is headquartered
LocationHeadquarters
- HQ city
- East Brunswick
- HQ country
- United States
- HQ region
- North America
Offices22 records
Markets served
Astera Cancer Care business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
Revenue model
- Medical Oncology Services: Chemotherapy, immunotherapy, and CAR T-cell therapy treatments for cancer patients
- Radiation Oncology Services: Advanced radiation treatments including IMRT, proton therapy, brachytherapy, and stereotactic radiosurgery
- Hematology Services: Diagnosis, treatment and management of blood disorders
- Infusion Services: Infusion treatments for chronic conditions including Rheumatoid Arthritis, Multiple Sclerosis, and Asthma
- Pharmacy Services: On-site pharmacy services for medication management and delivery
- Clinical Trials: Research participation generating revenue through clinical trial conduct and research partnerships
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Medical Oncology Treatment |
| Subscription | Multi-year contract | Radiation Oncology |
| Subscription | Multi-year contract | Infusion Services |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
Astera Cancer Care product offering
Product offeringCore offering
Astera Cancer Care is a physician-owned multi-specialty community oncology practice delivering coordinated, patient-centered cancer and hematology care through medical oncology, radiation oncology, breast care, infusion, pharmacy, clinical trials, palliative care, and social work services. The practice treats cancer and blood disorders using advanced therapies including CAR T-cell therapy, proton therapy, IMRT, SBRT, SRS, brachytherapy, and theranostics across 15+ locations in New Jersey and Pennsylvania.
Product overview
Astera Cancer Care is a physician-owned multi-specialty community oncology practice delivering coordinated, patient-centered cancer care. The organization operates as a unified platform combining Medical Oncology (chemotherapy, immunotherapy, CAR T-cell therapy), Radiation Oncology (IMRT, SBRT, SRS, proton therapy, TomoTherapy, brachytherapy), Hematology, Breast Care, Infusion Services, Pharmacy, Clinical Trials, Palliative Care, and Social Work. Specialized services include Theranostics, Deep Inspiration Breath Hold techniques, and SpaceOAR Hydrogel procedures. The network also includes TONO Dermatology for oncodermatology services. As a partner within the OneOncology network, the practice integrates research capabilities with community-based care delivery.
Differentiator
Problem solved
Functional benefit
Products and services
- Medical Oncology
Quantifiable outcome
- Access to cutting-edge cancer research studies and exclusive clinical trials available to only a small number of communities in the U.S.
Companies that use Astera Cancer Care
Customer profileNamed customers4 records
Segments6 records
Ideal customer profiles2 records
Astera Cancer Care technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Astera Cancer Care partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- OneOncologycoreAstera Cancer Care is a partner oncology practice within the OneOncology network, which provides practice management resources, technology, and operational support for independent oncology practices to compete effectively in the evolving healthcare landscape
- START Center for Cancer ResearchcoreCollaboration with START Center for Cancer Research to expand clinical research capabilities, with Dr. Neel Belani joining as Clinical Investigator at START New Jersey through the Astera partnership. The clinical trial site serves an estimated 10 million addressable population with approximately 150,000 new cancer cases annually
- Princeton Radiation OncologyminorNetwork partnership with Princeton Radiation Oncology for integrated radiation oncology services
- Astera UrologyminorNetwork partnership with Astera Urology for integrated urology oncology services
Scale indicators3 records
Recent moves7 records
Expansion highlights5 records
Astera Cancer Care competitors and assessment
Company assessmentDirect peers
- Regional Cancer Care Associates: Large multi-specialty community oncology practice in the Northeast/NJ market offering medical oncology, radiation oncology, and hematology across many sites; directly competes for referrals and physician talent in overlapping New Jersey sub-markets.
- New York Cancer & Blood Specialists: Community oncology practice delivering medical oncology, hematology, radiation oncology, and clinical trials across Long Island, NYC, and upstate NY; highly comparable multi-specialty, multi-site community oncology model with advanced services.
- Florida Cancer Specialists & Research Institute: One of the largest U.S. community oncology practices with a strong clinical trials program, multi-specialty services, and partnership history with OneOncology; provides a national scale benchmark for the Astera model.
- Tennessee Oncology: Large multi-site community oncology and hematology practice with significant clinical research footprint and OneOncology affiliation; comparable in scale, service breadth, and platform orientation to Astera.
Others
- OneOncology: National partnership network of independent community oncology practices; Astera is a partner practice within OneOncology, making it both a strategic affiliate and the closest organizational comparison for platform economics and shared services.
- START Center for Cancer Research: Global early-phase clinical trial site network partnered with Astera for START New Jersey; functionally a research partner, but its other U.S. sites provide a peer benchmark for community-embedded clinical research operations.
Broad incumbents
- City of Hope Cancer Center: Large NCI-designated comprehensive cancer center with extensive community oncology expansion and acquisition activity; competes for complex cases and increasingly for community referrals in Astera's region.
- The US Oncology Network: National network of community oncology practices affiliated with McKesson, providing practice management, technology, and clinical research infrastructure; broader incumbent counterpart to OneOncology with overlapping affiliate model.
- Penn Medicine Abramson Cancer Center: NCI-designated academic cancer center operating radiation oncology services at Plainsboro, NJ (where Astera also operates); represents the academic competitor whose employed-physician strategy directly contests Astera's community oncology positioning.
Regional players
- Atlantic Health System Cancer Care: Integrated health system-based oncology service line with multiple NJ locations including Morristown and Overlook; competing hospital-employed oncology option in Astera's core NJ service area.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks1 record
Key highlights7 records
Customer concentration
Astera Cancer Care social profiles
Digital presenceAstera Cancer Care compliance and trust
Trust signalCompliance1 record
Astera Cancer Care financial estimates
Financial estimateRevenue estimate
Valuation estimate
Astera Cancer Care leadership team
Management profileNumber of profiles
Profiles10 records
Astera Cancer Care subsidiaries and ownership
Company hierarchySubsidiaries1 record
Astera Cancer Care funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Astera Cancer Care M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Astera Cancer Care
What does Astera Cancer Care do?
Astera Cancer Care is a physician-owned multi-specialty community oncology practice delivering coordinated, patient-centered cancer and hematology care through medical oncology, radiation oncology, breast care, infusion, pharmacy, clinical trials, palliative care, and social work services. The practice treats cancer and blood disorders using advanced therapies including CAR T-cell therapy, proton therapy, IMRT, SBRT, SRS, brachytherapy, and theranostics across 15+ locations in New Jersey and Pennsylvania.
When was Astera Cancer Care founded?
Astera Cancer Care was founded in 2021. It employs 101 to 250 people.
Where is Astera Cancer Care based?
Astera Cancer Care is headquartered in East Brunswick, United States, in the North America region.
How does Astera Cancer Care make money?
Six revenue lines are on record. Medical Oncology Services are the primary driver. The others are radiation Oncology Services, hematology Services, infusion Services, pharmacy Services and clinical Trials.
Who are Astera Cancer Care's main competitors?
Direct peers on record are Regional Cancer Care Associates, New York Cancer & Blood Specialists, Florida Cancer Specialists & Research Institute and Tennessee Oncology. Others are OneOncology and START Center for Cancer Research. Broad incumbents are City of Hope Cancer Center, The US Oncology Network and Penn Medicine Abramson Cancer Center. Atlantic Health System Cancer Care is listed as a regional player.
Does Astera Cancer Care have an API?
No public API is recorded for Astera Cancer Care.
What industry is Astera Cancer Care in?
Astera Cancer Care's product category is Oncology and Hematology Healthcare Services. Its primary akta.pro industry code is HLAKAFAB, Medical Oncology, with a secondary code of HLAKAFAC, Radiation Oncology. Its NAICS code is 6211 and its SIC code is 8011.